CL
ITCI
CSS LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,904
| Closed | -$3.81M | – | 940 |
|
|
2025
Q1 | $3.81M | Buy |
+28,904
| New | +$3.81M | 0.21% | 67 |
|
|
2023
Q1 | – | Sell |
-44,189
| Closed | -$2.34M | – | 755 |
|
|
2022
Q4 | $2.34M | Sell |
44,189
-1,066
| -2% | -$56.4K | 0.13% | 126 |
|
|
2022
Q3 | $2.11M | Sell |
45,255
-14,513
| -24% | -$675K | 0.1% | 170 |
|
|
2022
Q2 | $3.41M | Sell |
59,768
-773
| -1% | -$44.1K | 0.14% | 134 |
|
|
2022
Q1 | $3.71M | Buy |
60,541
+34,287
| +131% | +$2.1M | 0.13% | 123 |
|
|
2021
Q4 | $1.37M | Buy |
26,254
+4,682
| +22% | +$245K | 0.05% | 280 |
|
|
2021
Q3 | $804K | Buy |
21,572
+17,299
| +405% | +$645K | 0.03% | 379 |
|
|
2021
Q2 | $174K | Sell |
4,273
-26,515
| -86% | -$1.08M | 0.01% | 688 |
|
|
2021
Q1 | $1.05M | Sell |
30,788
-18,800
| -38% | -$638K | 0.04% | 305 |
|
|
2020
Q4 | $1.58M | Sell |
49,588
-15,398
| -24% | -$490K | 0.06% | 170 |
|
|
2020
Q3 | $1.67M | Buy |
64,986
+39,101
| +151% | +$1M | 0.08% | 131 |
|
|
2020
Q2 | $664K | Buy |
25,885
+2,303
| +10% | +$59.1K | 0.04% | 203 |
|
|
2020
Q1 | $362K | Buy |
23,582
+11,957
| +103% | +$184K | 0.03% | 222 |
|
|
2019
Q4 | $399K | Buy |
+11,625
| New | +$399K | 0.02% | 271 |
|